These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1604701)

  • 1. The impact of T cells in nonspecific destruction of beta cells in mice.
    Nagata M; Mullen Y; Matsuo S; Wicker LS; Peterson LB
    Transplant Proc; 1992 Jun; 24(3):988-9. PubMed ID: 1604701
    [No Abstract]   [Full Text] [Related]  

  • 2. Destruction of islet isografts by severe nonspecific inflammation.
    Nagata M; Mullen Y; Matsuo S; Herrera M; Clare-Salzler M
    Transplant Proc; 1990 Apr; 22(2):855-6. PubMed ID: 2109420
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of recurrent diabetes in syngenic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes.
    Utsugi T; Nagata M; Kawamura T; Yoon JW
    Transplantation; 1994 Jun; 57(12):1799-804. PubMed ID: 7912459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenoreactive T-cell lines initiate pancreatic islet graft destruction in vivo.
    Wolf L; Gill RG
    Transplant Proc; 1993 Feb; 25(1 Pt 1):440-1. PubMed ID: 8438369
    [No Abstract]   [Full Text] [Related]  

  • 5. Islet protective effect of pravastatin from nonspecific inflammation in mouse pancreatic islet isografts.
    Arita S; Saul J; Joh S; Kasraie A; Atiya A; Une S; Ohtsuka S; Mullen Y
    Transplant Proc; 1996 Apr; 28(2):924. PubMed ID: 8623465
    [No Abstract]   [Full Text] [Related]  

  • 6. Causes of islet allograft primary nonfunction.
    Liu M; Shapiro ME
    Transplant Proc; 1995 Dec; 27(6):3205-7. PubMed ID: 8539915
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection of mouse islet isografts from early transplantation damage by nicotinamide treatment of recipients.
    Kenmochi T; Mullen Y; Miyamoto M; Stein E
    Transplant Proc; 1994 Apr; 26(2):693. PubMed ID: 8171611
    [No Abstract]   [Full Text] [Related]  

  • 8. Nature of tolerance induction to peripheral (extrathymic) islet allografts.
    Coulombe M; Lafferty KJ; Gill RG
    Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624
    [No Abstract]   [Full Text] [Related]  

  • 9. Syngeneic islets transplanted into the thymus of newborn mice prevent diabetes and reduce insulitis in the NOD mouse.
    Nomura Y; Mullen Y; Stein E
    Transplant Proc; 1993 Feb; 25(1 Pt 2):963-4. PubMed ID: 8442281
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of anti-T-lymphocyte monoclonal antibody (5G2) therapy for prolongation of canine islet allograft survival.
    Brendel MD; Schachner RS; Kong SS; Qian T; Alejandro R; Mintz DH
    Transplant Proc; 1994 Apr; 26(2):743-4. PubMed ID: 8171637
    [No Abstract]   [Full Text] [Related]  

  • 11. CD4+ T cells are both necessary and sufficient for islet xenograft rejection.
    Gill RG; Wolf L; Daniel D; Coulombe M
    Transplant Proc; 1994 Jun; 26(3):1203. PubMed ID: 7913259
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice.
    Mandel T; Dillon H; Koulmanda M
    Transplant Proc; 1995 Dec; 27(6):3569. PubMed ID: 8540105
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetic BB/PFD rats reject MHC incompatible islet grafts, but do not destroy MHC compatible islet grafts.
    Mathieu C; Waer M; Kuttler B; Hahn HJ; Bouillon R
    Transplant Proc; 1994 Apr; 26(2):718-9. PubMed ID: 8171623
    [No Abstract]   [Full Text] [Related]  

  • 14. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and morphologic characterization of renal subcapsular islet isografts in rats treated with FK 506.
    Ueki M; Yasunami Y; Ryu S; Arima T; Ikeda S; Tanaka M
    Transplant Proc; 1994 Apr; 26(2):740. PubMed ID: 7513469
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment.
    Fukuzaki T; Gotoh M; Monden M; Dono K; Wada H; Kita Y; Kanai T; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):975. PubMed ID: 7680173
    [No Abstract]   [Full Text] [Related]  

  • 17. Reinnervation of transplanted pancreatic islets: a comparison between islets implanted into the kidney, spleen, or liver.
    Korsgren O; Jansson L; Andersson A; Sundler F
    Transplant Proc; 1992 Jun; 24(3):1025-6. PubMed ID: 1604506
    [No Abstract]   [Full Text] [Related]  

  • 18. Approaches to the prevention of immune destruction of transplanted pancreatic islets.
    Lafferty KJ; Hao L
    Transplant Proc; 1994 Apr; 26(2):399-400. PubMed ID: 8171476
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant immunotherapy with Bacillus Calmette-Guerin prevents recurrence of diabetes in islet grafts transplanted into NOD mice.
    Lakey JR; Warnock GL; Singh B; Rajotte RV
    Transplant Proc; 1994 Apr; 26(2):736. PubMed ID: 8171632
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-specific vs. autoimmune destruction of islet grafts in mice.
    Nagata M; Mullen Y; Herrera M; Matsuo S
    Horm Metab Res Suppl; 1990; 25():153-6. PubMed ID: 2088958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.